Home » Topics » BioWorld Science

BioWorld Science
RSS

Health Canada clears phase I trial of AC-1101 for vitiligo

May 8, 2020

RBN-2397: a first-in-class PARP-7 inhibitor with oral antitumor activity

May 8, 2020

Pfizer presents phase II data for PF-06480605 in ulcerative colitis

May 8, 2020

MGH reports progress in development of a novel gene-based COVID-19 vaccine

May 8, 2020

Positive preclinical data support IND application for CardiALLO therapy in heart failure

May 8, 2020

FDA approves IND for Organicell Flow as treatment of SARS due to COVID-19

May 8, 2020

Cabo as next annual shot?

May 8, 2020

Antibiotics affect oxycodone effects

May 8, 2020

FDA clears new phase I study of NBTXR-3 activated by radiation therapy for pancreatic cancer

May 7, 2020

FDA approves Tabrecta for metastatic NSCLC with METex14

May 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...